These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 936674

  • 1. [Formation of urinary calculi due to overdosage of dihydrotachysterol].
    Lenk S, Brien G, Bick C.
    Z Arztl Fortbild (Jena); 1976 May 01; 70(9):470-1. PubMed ID: 936674
    [No Abstract] [Full Text] [Related]

  • 2. [Iatrogenic kidney-calculi formation and kidney failure due to long-term treatment with calcinosis factors (dihydrotachysterol, vitamin D)].
    Gebhardt K.
    Z Arztl Fortbild (Jena); 1977 May 01; 71(9):447-9. PubMed ID: 878519
    [No Abstract] [Full Text] [Related]

  • 3. [Nil nocere. Renal calcinosis following long-term treatment with dihydrotachysterol].
    Stocker WG.
    Munch Med Wochenschr; 1972 Apr 07; 114(14):653-5. PubMed ID: 5067876
    [No Abstract] [Full Text] [Related]

  • 4. [An indication of long-term dihydrotachysterin-(AT 10)- overdosage].
    Dinkel L.
    Fortschr Geb Rontgenstr Nuklearmed; 1967 Oct 07; 107(4):494-7. PubMed ID: 5628424
    [No Abstract] [Full Text] [Related]

  • 5. [Nephrocalcinosis caused by dihydrotachysterol therapy].
    Forsström J, Kasanen A, Sutinen S.
    Duodecim; 1971 Oct 07; 87(19):1331-6. PubMed ID: 5133057
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. ["Calcium gout" with nephrocalcinosis due to long-term dihydrotachysterine therapy].
    Schellhorn W.
    Med Klin; 1967 Aug 11; 62(32):1232-7. PubMed ID: 4298777
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Morphology and adenosine phosphate in experimental nephrocalcinosis].
    Lunglmayr G, Schwarzmeier J.
    Z Gesamte Exp Med Einschl Exp Chir; 1968 Aug 11; 148(3):204-9. PubMed ID: 5728873
    [No Abstract] [Full Text] [Related]

  • 15. [Experimental production of urinary calculi in rats by combined administration of calcinosis factor and calcium salts].
    Bromig G, Andreadis P.
    Z Urol Nephrol; 1967 Jun 11; 60(6):369-71. PubMed ID: 5596641
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Contribution to the study of the influence of the thyroparathyroid system on nephrocalcinosis. 3. Effects of total or partial excision of the thyroparathyroid system on nephrocalcinosis with dihydrotachysterol (DHT) in rats].
    Girard G.
    Laval Med; 1966 Nov 11; 37(9):968-78. PubMed ID: 5983856
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Urinary calculi associated with nephrocalcinosis.
    ENGEL WJ.
    J Urol; 1952 Jul 11; 68(1):105-16. PubMed ID: 14939441
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.